ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Puerto Rico » Internal Medicine

Top Internal Medicine Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PEDRO LOPEZ LOPEZ

Internal Medicine

47,079

$1.66M

1216
745 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $35

ROBERTO GONZALEZ M.D.

Internal Medicine

46,766

$1.54M

1307
917 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

NELSON RIVERA RIVERA M.D.

Internal Medicine

46,429

$1.16M

960
738 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$25
Average prescription price

Avg: $35

JOSE DE LEON M.D.

Internal Medicine

40,691

$1.08M

1406
1028 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$27
Average prescription price

Avg: $35

JUAN ORTIZ MATOS MD

Internal Medicine

40,086

$1.15M

935
596 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$29
Average prescription price

Avg: $35

MANUEL MATEO LOPEZ 11772

Internal Medicine

37,887

$1.24M

1250
895 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

RAFAEL RUIZ GONZALEZ M.D

Internal Medicine

34,846

$1.02M

1016
724 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$29
Average prescription price

Avg: $35

CARLOS MUNIZ MOLINERO MD

Internal Medicine

33,915

$1.76M

1273
853 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $35

RICARDO JIMENEZ M.D.

Internal Medicine

33,397

$1.01M

893
652 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $35

EVELYN MATTA FONTANET M.D.

Internal Medicine

32,106

$1.05M

1097
836 are 65+

1%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

RICARDO BLONDET VISSEPO M.D.

Internal Medicine

31,907

$1.22M

1058
818 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$38
Average prescription price

Avg: $35

CARLOS CEPERO AYENDE M.D.

Internal Medicine

30,261

$888K

900
550 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$29
Average prescription price

Avg: $35

MARIO MALDONADO MD

Internal Medicine

29,684

$1.38M

1021
660 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $35

LUZ MARRERO MD

Internal Medicine

29,175

$864K

831
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$30
Average prescription price

Avg: $35

CARLOS MALDONADO M.D.

Internal Medicine

28,219

$986K

737
556 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $35

MIGUEL RODRIGUEZ MD

Internal Medicine

27,089

$929K

827
507 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $35

ELLIOT MELECIO M.D.

Internal Medicine

26,740

$1.09M

828
600 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$41
Average prescription price

Avg: $35

VICTOR POLANCO SANCHEZ M.D.

Internal Medicine

26,662

$840K

874
563 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$32
Average prescription price

Avg: $35

VICTOR LOPEZ-LLAVONA MD

Internal Medicine

26,587

$826K

872
539 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$31
Average prescription price

Avg: $35

AUSBERTO ALEJANDRO BENITEZ

Internal Medicine

26,141

$942K

926
664 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $35

CARLOS RAMOS M.D.

Internal Medicine

26,011

$877K

1099
786 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $35

CARRIE BACO MD

Internal Medicine

25,837

$1.04M

723
581 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $35

JUAN NEGRON M.D.

Internal Medicine

25,583

$796K

847
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$31
Average prescription price

Avg: $35

JAMIL ABOUELHOSSEN MD

Internal Medicine

25,464

$993K

1085
853 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $35

PABLO ROBLES CORTES M.D.

Internal Medicine

24,977

$822K

921
718 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$33
Average prescription price

Avg: $35

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank